DRT in potential levfin M&A deal pipeline

Private equity firm Ardian is ready to tap Europe’s leveraged finance markets to fund the acquisition of a controlling stake in Dérivés Résiniques et Terpéniques (DRT), the French plant chemistry specialist, but there are mixed views on the outlook for further M&A-fuelled leveraged finance activity.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: